Childhood Asthma: A Complete Guide to Diagnosis, Treatment, and Long-Term Control

Dr. Divyank Pathak 02 July 2026

Asthma is the most common chronic respiratory condition in children, and it remains one of the most consistently under-diagnosed and under-treated conditions in the Varanasi and Uttar Pradesh region. At Vatsalya Superspeciality Children Hospital, I run one of Uttar Pradesh's few dedicated paediatric allergy and asthma centres, and a significant proportion of children I see have been managing their symptoms for months or years before receiving a proper diagnosis. This guide explains what childhood asthma actually is, how it is diagnosed, how it is treated, and what long-term control looks like in practice.

What is childhood asthma and why is it so often missed?

Asthma is a chronic inflammatory condition of the airways characterised by variable airflow obstruction and bronchial hyperresponsiveness. The airways become inflamed, swell, and produce excess mucus, making it difficult to breathe. This obstruction is typically reversible, but in poorly controlled asthma the inflammation persists and the airways can remodel over time. The key reason childhood asthma is frequently missed in India is that its most common presentation in young children is a persistent cough, particularly at night or early morning, rather than the classic wheeze. Parents and sometimes even general practitioners attribute this cough to repeated infections, adenoids, or post-nasal drip, and the child cycles through antibiotics without anyone asking whether the underlying problem is allergic airway inflammation.

The allergic march: how asthma fits into a bigger picture

Understanding asthma in children requires understanding the concept of the allergic march, the sequential development of allergic conditions that often begins in infancy. A baby who develops eczema in the first year of life, then develops allergic rhinitis, then develops asthma is following the most common trajectory of atopic disease. These conditions are not separate problems. They reflect the same underlying immune dysregulation expressing itself in different organs at different developmental stages.

In my practice, I always evaluate a child with suspected asthma for the full range of atopic conditions. A child whose asthma is treated in isolation, while undiagnosed allergic rhinitis continues to drive upper airway inflammation and postnasal drip into the lower airway, will have persistently poorly controlled asthma regardless of how good the inhaled treatment is. The upper and lower airways must be assessed and managed together.

Triggers: understanding what drives asthma in children

Not all asthma has the same triggers, and identifying the specific triggers relevant to each child is one of the most practically useful parts of the initial assessment. The most common triggers for asthma in children in Varanasi include house dust mites, which thrive in the humid North Indian climate and in traditional cotton-stuffed bedding; cockroach allergens, which are a significant sensitising agent in dense urban settings; outdoor pollen, which varies seasonally; and respiratory viral infections, which are by far the most common trigger for acute wheeze in younger children under five.

Non-allergic triggers also play a role. Cold air, smoke from cooking fires and crop burning, vehicle emissions, exercise, and strong emotional responses can all provoke airway narrowing in a child with underlying bronchial hyperresponsiveness. Identifying which triggers are relevant for a particular child allows targeted avoidance advice rather than the generic and often impractical instructions to avoid dust and cold that families frequently receive without further specificity.

How is childhood asthma diagnosed?

Clinical history and examination

The diagnosis of asthma is primarily clinical. A detailed history is the most important diagnostic tool. I ask specifically about the pattern of respiratory symptoms, their frequency and timing, what makes them better or worse, whether there is a family history of asthma or allergic disease, and what the home environment is like. A child with recurrent wheezing that improves with bronchodilator treatment, especially one with eczema, allergic rhinitis, or a strong family history of atopy, has a high pre-test probability of asthma even before any investigation is performed.

Spirometry and pulmonary function testing

In children aged five and above who can cooperate with the test, spirometry provides objective evidence of airflow obstruction and its reversibility. A significant improvement in FEV1 after inhaled bronchodilator supports a diagnosis of asthma. Spirometry also provides baseline lung function data that is essential for monitoring disease progression over time. I perform pulmonary function testing at Vatsalya Children Hospital, and this investigation forms a standard part of the asthma work-up in school-age children.

Allergy testing

Skin prick testing is the gold standard for identifying specific allergen sensitisation. Small amounts of standardised allergen extracts are applied to the forearm skin and a positive wheal response confirms IgE-mediated sensitisation to that allergen. In children with asthma, I routinely test for house dust mite, cockroach, moulds, pollen, and common food allergens. Knowing which allergens are driving a child's sensitisation allows targeted environmental control advice and determines whether the child is a candidate for allergen immunotherapy. Serum-specific IgE testing provides an alternative where skin prick testing is not possible.

How is childhood asthma classified and why does it matter?

Asthma is not a single uniform condition. It exists on a spectrum from mild intermittent symptoms to severe persistent disease, and treatment is stepped up or down based on where a child sits on this spectrum. Classification also considers the asthma phenotype, since different phenotypes respond differently to treatment. Allergic asthma, the most common phenotype in children, responds well to inhaled corticosteroids and allergen avoidance. Non-allergic asthma, which is more common in older adolescents and adults, may require different therapeutic strategies.

Treatment: the stepped approach to asthma management

Reliever therapy

Short-acting bronchodilators, primarily salbutamol inhaler or equivalent, are used for immediate relief of acute symptoms. They work by relaxing the muscles around the airways, allowing them to widen and improve airflow. Reliever therapy does not treat the underlying inflammation, which is why a child who is using a reliever more than twice a week needs to be assessed for controller therapy rather than simply supplied with more reliever.

Controller therapy

Inhaled corticosteroids are the cornerstone of controller therapy in childhood asthma. They reduce airway inflammation, decrease the frequency of symptoms and exacerbations, and prevent long-term airway remodelling. At appropriate doses, inhaled corticosteroids have an excellent safety profile in children. The risks of uncontrolled asthma significantly outweigh the risks of well-prescribed inhaled therapy. For children whose asthma is not adequately controlled with inhaled corticosteroids alone, additional controller medications including long-acting bronchodilators or antileukotriene agents may be added in a stepped approach. I review controller therapy at every consultation, stepping up when symptoms are not controlled and stepping down when the child has been stable for an extended period.

Inhaler technique: the most underestimated barrier to asthma control

A consistent finding across paediatric asthma practice in India is that poor inhaler technique is one of the primary reasons for inadequate asthma control, even when the right medication has been prescribed. A child using a metered-dose inhaler without a spacer is likely delivering only a fraction of the dose to the lungs. A child using a dry powder inhaler without the strength and coordination to generate adequate inspiratory flow is in a similar position. At every consultation, I review inhaler technique directly with the child and the parent. Correct technique, consistently applied, makes an enormous difference to real-world asthma control.

What is difficult-to-treat or severe asthma?

A child is said to have difficult-to-treat asthma when symptoms persist despite appropriate controller therapy at adequate doses with good inhaler technique. Before escalating treatment, it is important to systematically address several common reasons for apparent treatment resistance: poor adherence to prescribed medication, ongoing allergen exposure that has not been adequately addressed, untreated comorbidities such as allergic rhinitis, obesity, or gastro-oesophageal reflux, and incorrect inhaler technique.

True severe asthma, where symptoms persist even after all of the above have been adequately addressed, requires specialist evaluation and may involve advanced therapies including biological agents targeting specific inflammatory pathways. These treatments are available in selected cases and have significantly improved outcomes for children with refractory disease. As the director of a dedicated paediatric allergy and asthma centre, I evaluate and manage children with difficult-to-treat and severe asthma using structured assessment protocols informed by my training at Sir Ganga Ram Hospital and the University of Colorado.

Allergen immunotherapy: the disease-modifying option

Allergen immunotherapy is the only treatment that modifies the underlying allergic disease rather than suppressing its symptoms. It works by gradually exposing the immune system to increasing doses of the specific allergen, inducing a shift in the immune response that reduces allergic reactivity over time. Evidence supports its effectiveness in reducing asthma symptoms, improving lung function, reducing medication requirements, and in many cases preventing the development of new sensitivities.

I offer both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) for appropriate candidates. The decision on which route is most suitable depends on the specific allergen, the child's age and compliance, and the family's capacity for the treatment schedule. The full course typically lasts three to five years, and benefits persist well beyond the treatment period. Immunotherapy is considered in children with confirmed allergen sensitisation whose asthma and associated rhinitis are not adequately controlled with pharmacotherapy alone.

Asthma education and the role of the family

One of the most consistent predictors of good asthma control is family engagement with the management plan. A parent who understands what asthma is, why the controller inhaler matters even when the child feels well, what an exacerbation looks like and when to seek help, and how to use the inhaler correctly is a central part of the treatment team. I spend time at every consultation on asthma education for parents, including a written asthma action plan that specifies exactly what to do at each level of symptom severity.

Common mistakes families make include stopping the controller inhaler when the child appears well, using the reliever as the first response to any symptom without reviewing whether the controller dose is adequate, and delaying hospital presentation during a severe episode because the child has had similar episodes before. Addressing these patterns through education reduces emergency admissions and hospitalisation rates significantly.

Asthma in school and physical activity

Children with asthma should not be excluded from school activities or sports. Exercise is beneficial for respiratory health, cardiovascular fitness, and general wellbeing. Exercise-induced asthma in children is manageable with appropriate pre-exercise bronchodilator use and, where indicated, environmental modification during exercise. I provide families with clear guidance on how to approach physical activity safely, and I communicate with schools where necessary to ensure that teachers understand the child's condition and know what to do in the event of a symptom episode during school hours.

A child with well-controlled asthma can participate fully in sports and physical education. Restricting physical activity in a child with asthma is appropriate only as a temporary measure during an acute exacerbation, not as a long-term strategy.

Questions parents ask me most often

At what age can asthma be diagnosed in children?

Asthma can be diagnosed at any age, though the diagnosis in children under five is made clinically based on the pattern of symptoms and response to treatment, since spirometry is not reliably performed at this age. Recurrent wheeze in a young child with eczema and a family history of atopy has a high probability of representing asthma even in infancy.

Will my child outgrow asthma?

Many children experience significant improvement in asthma symptoms in adolescence, particularly boys with mild disease. However, a substantial proportion continue to have symptoms into adult life, and some who appear to outgrow asthma in their teens experience recurrence in early adulthood. Allergen immunotherapy in childhood may improve the long-term trajectory. The goal of management is not simply to wait and see but to control symptoms effectively in the present while monitoring the pattern over time.

Are inhaled steroids safe for long-term use in children?

Yes. Inhaled corticosteroids at the doses used in childhood asthma management have a well-established safety profile. The evidence base for their use is robust and spans decades. The risks of uncontrolled asthma, to lung development, to school attendance, to quality of life, and to long-term respiratory function, significantly outweigh the risks of well-prescribed and monitored inhaled therapy.

How often does my child need to be seen?

The frequency of follow-up depends on the severity of the asthma and how well it is controlled. A child with newly diagnosed asthma or one who has recently had a change in treatment is typically reviewed every four to six weeks initially. Once stable, six-monthly review is appropriate for most children, with spirometry annually. I also ask families to contact me directly if symptoms change between appointments rather than waiting for the next scheduled visit.

If your child has a recurrent cough, wheeze, or breathing difficulty that has not been properly evaluated, or if they have been diagnosed with asthma and their symptoms are not well controlled, a specialist consultation can make a meaningful difference. To book an appointment with Dr Divyank Pathak at Vatsalya Superspeciality Children Hospital, Varanasi, call +91 983871311.

Written by Dr Divyank Pathak, MBBS, MD (Pediatrics), IFPCCM, DPAA, FNPP, DPSM, FAAP, Director and Senior Consultant Paediatrician, Pediatric Critical Care and Allergy and Asthma Specialist, Vatsalya Superspeciality Children Hospital, Mahavir Road, Varanasi, Uttar Pradesh 221002.